{"title":"CDM IS DEAD","authors":"Joseph Anderson","doi":"10.14524/CR-15-4098","DOIUrl":null,"url":null,"abstract":"Few areas of clinical development have undergone as much change in the last 10 years as clinical data management (CDM). Its demise has been predicted and assumed for decades, aided and abetted by large consultancies and investors/analysts pressuring pharma for cost-cutting. These stakeholders saw (","PeriodicalId":90809,"journal":{"name":"Clinical researcher (Alexandria, Va.)","volume":"23 1","pages":"58-60"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical researcher (Alexandria, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14524/CR-15-4098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Few areas of clinical development have undergone as much change in the last 10 years as clinical data management (CDM). Its demise has been predicted and assumed for decades, aided and abetted by large consultancies and investors/analysts pressuring pharma for cost-cutting. These stakeholders saw (